Suppression of Dendritic Cell-Derived IL-12 by Endogenous Glucocorticoids Is Protective in LPS-Induced Sepsis.

PLoS Biol

Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.

Published: October 2015


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Sepsis, an exaggerated systemic inflammatory response, remains a major medical challenge. Both hyperinflammation and immunosuppression are implicated as causes of morbidity and mortality. Dendritic cell (DC) loss has been observed in septic patients and in experimental sepsis models, but the role of DCs in sepsis, and the mechanisms and significance of DC loss, are poorly understood. Here, we report that mice with selective deletion of the glucocorticoid receptor (GR) in DCs (GR(CD11c-cre)) were highly susceptible to LPS-induced septic shock, evidenced by elevated inflammatory cytokine production, hypothermia, and mortality. Neutralizing anti-IL-12 antibodies prevented hypothermia and death, demonstrating that endogenous GC-mediated suppression of IL-12 is protective. In LPS-challenged GR(CD11c-cre) mice, CD8(+) DCs were identified as the major source of prolonged IL-12 production, which correlated with elevations of NK cell-derived IFN-γ. In addition, the loss of GR in CD11c(+) cells rescued LPS-induced loss of CD8(+) DCs but not other DC subsets. Unlike wild-type animals, exposure of GR(CD11c-cre) mice to low-dose LPS did not induce CD8(+) DC loss or tolerance to subsequent challenge with high dose, but neutralization of IL-12 restored the ability of low-dose LPS to tolerize. Therefore, endogenous glucocorticoids blunt LPS-induced inflammation and promote tolerance by suppressing DC IL-12 production.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595142PMC
http://dx.doi.org/10.1371/journal.pbio.1002269DOI Listing

Publication Analysis

Top Keywords

endogenous glucocorticoids
8
grcd11c-cre mice
8
cd8+ dcs
8
il-12 production
8
low-dose lps
8
il-12
5
loss
5
suppression dendritic
4
dendritic cell-derived
4
cell-derived il-12
4

Similar Publications

Background: Glucocorticoids (GCs) are key regulators of hematopoiesis, but the effects of chronically elevated endogenous GC levels on hematopoietic stem cell (HSC) function and immune cell development remain poorly understood.

Methods: We used a mouse model with adrenocortical cell-specific deletion of hypoxia-inducible factor-1 alpha (HIF1α; P2H1), which results in sustained and systemic elevation of GC. Hematopoietic stem and progenitor cell (HSPC) populations were analyzed phenotypically and functionally.

View Article and Find Full Text PDF

Summary: We present the case of a 52-year-old Caucasian woman with insulin autoimmune syndrome (IAS) uncovered after corticosteroid treatment for lumbar pain due to disc herniation. We confirmed hypoglycemic episodes 4-5 h after food ingestion, associated with extremely high levels of insulin and the presence of anti-insulin antibodies, establishing the diagnosis of IAS. The most probable cause of the disease was glucocorticoid medication, considering she had no other autoimmune or hematologic disease associated.

View Article and Find Full Text PDF

LHX3 mutation in dogs is associated with combined pituitary hormone deficiency. However, ACTH secretion is usually preserved. A 9-week-old female White Swiss Shepherd dog presented with growth retardation and was diagnosed with pituitary dwarfism due to LHX3 mutation.

View Article and Find Full Text PDF

Toxic encephalopathy is a central nervous system disorder caused by endogenous or exogenous toxic substances. Granzyme B (GZMB), a key serine protease, plays a crucial role in immune regulation and the progression of various diseases. Abnormal expression of GZMB may contribute to the development and progression of toxic encephalopathy; however, its specific mechanisms remain unclear.

View Article and Find Full Text PDF

Therapeutic potential of cannabinoids for treating atopic dermatitis.

J Cannabis Res

August 2025

Faculty of Pharmaceutical Sciences, Universidade Estadual de Campinas, Rua Cândido Portinari, 200, Cidade Universitária Zeferino Vaz, Campinas, São Paulo, 13083-871, Brazil.

This review aims to assess the therapeutic potential of cannabinoids as complementary treatments for atopic dermatitis. Atopic dermatitis (AD) is a skin disease characterized by the loss of skin barrier function that promotes subsequent symptoms such as intense itching, xerosis and inflammation. Several treatments are available, particularly topical approaches, which are crucial for both acute and chronic management of the disease.

View Article and Find Full Text PDF